Interleukin-7 Gene Transfer in Patients with Metastatic Colon Carcinoma, Renal Cell Carcinoma, Melanoma, or with Lymphoma. Universitaetsklinikum Rudolf Virchow, Standort Charlottenburg, Germany
Authors:
- Ingo G. H. Schmidt-WolfISIngo G. H. Schmidt-Wolf
- 1 September 1994
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 5 (9) , 1161-1168
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- At Age 2, Gene Therapy Enters a Growth PhaseScience, 1992
- Human gene therapy comes of ageNature, 1992
- Interleukin 7 induces CD4+ T cell-dependent tumor rejection.Journal of Experimental Medicine, 1991
- Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.Proceedings of the National Academy of Sciences, 1991
- Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.Journal of Experimental Medicine, 1991
- Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4Molecular Immunology, 1990
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.Journal of Experimental Medicine, 1990
- Retroviral interleukin 4 gene transfer into an interleukin 4‐dependent cell line results in autocrine growth but not in tumorigenicityEuropean Journal of Immunology, 1990
- Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2Immunology Letters, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990